Released May 10, 2016, after the close
10-Q filed May 10, 2016, 40 days after period end · 0001104659-16-119768
Q1 2016 · 10-Q
Revenue$66.04M$66.04M +128.3% vs Q1 2015+23.9% vs Q4 2015
Net Income-$13.30M-$13.30M no prior Q1 2015 on fileno prior Q4 2015 on file
EPS Diluted-$0.09-$0.09 N/M vs Q1 2015N/M vs Q4 2015
Operating Income-$1,968,000N/M
Operating Cash Flow$161,000N/M
Free Cash Flowderived-$847,000N/M
Margins · derived
Operating margin-3.0%+94.0 pt vs Q1 2015
Net margin-20.1%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $66.04M | $28.93M | $14.61M | $3.26M |
| Net Income | -$13.30M | — | — | — |
| EPS Diluted | -$0.09 | -$0.24 | -$0.38 | -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR